Clinical Trial Update: European Trial of Pirfenidone in BOS, A European Multi-center Study [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 European trial of pirfenidone in Bronchiolitis Obliterans related to lung transplant (CLAD) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans
• Lung Allograft Dysfunction

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Disorder Related to Lung Transplantation, CLAD, Bronchiolitis Obliterans | Phase 2, Phase 3 | Status: COMPLETED